Top compounds associated with response to MTA3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA AZD6244 CCLE pan-cancer AAC -0.16 0.0004
mRNA FH535 GDSC1000 pan-cancer AAC 0.12 0.0005
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.12 0.0005
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.13 0.0006
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.16 0.0007
mRNA A-770041 GDSC1000 pan-cancer AAC 0.18 0.0007
Download CSV